Heart Blocks Treatment Market Size worth US$ 7.40 billion by 2030 to grow at a CAGR of 4%| Growth Plus Reports

By GlobeNewswire On Nov 16, 2022

Pune, Nov. 16, 2022 (GLOBE NEWSWIRE) — According to the latest report published by Growth Plus Reports, the global Heart Blocks Treatment Market will clock US$ 7.40 billion by 2030. The rapidly increasing adoption of digitalization due to growing urbanization is a major driver for the Heart Blocks Treatment Market. This exclusive information is published by Growth Plus Reports in its report titled “Heart Blocks Treatment Market – Global Outlook & Forecast 2022-2030

Download Sample PDF Brochure of Heart Blocks Treatment Market:

https://growthplusreports.com/inquiry/request-sample/heart-blocks-treatment-market/7969

Market Drivers

The main factors driving the global heart block treatment market are the rising incidence of cardiovascular disorders and the growing worldwide elderly population. The increasing preference for minimally invasive cardiac procedures over open surgeries because of the shorter hospital stays, reduced risk of infection and bleeding, and faster recovery contributes significantly to the expansion of the global market. Additionally, the use of advanced technologies like AI to enhance pacemakers is on the rise. The risk of heart diseases is also rising due to an unhealthy lifestyle trend, obesity, and physical inactivity. Moreover, the continuous launch of new products and increase in investment by the top players in research and development is also anticipated to propel the global heart block treatment market.

The global heart blocks treatment market has been analyzed from four perspectives –

Type
Treatment
Region

Excerpts from ‘By Type Segmentation’

Based on types, the global heart blocks treatment market is divided into

First-Degree Heart Blocks
Second-Degree Heart Blocks
Third-Degree Heart Blocks

The first-degree heart blocks segment dominates the global heart block treatment market with the largest market share in 2021. The increase in the elderly population coupled with an unhealthy lifestyle and obesity can be attributed to the huge share of the first-degree heart blocks segment. Furthermore, the number of people living with heart problems is increasing as they are more susceptible to first-degree heart block. According to the British Heart Foundation, 1 out of 14 people worldwide live with heart or circulatory diseases, propelling the market growth. Athletes, adolescents, young adults, and those with a very active vagus nerve are other groups who frequently get first-degree heart block, which is also raises the need for first-degree heart block treatment.

Excerpts from ‘By Treatment Segmentation’

Based on treatment, the global heart blocks treatment market is categorized into

Pacemaker
Transcutaneous Pacing (TCP)
Medication
Follow-Up Electrophysiology Study

The pacemaker segment holds the largest market share of the global heart block market in 2021. A significant factor in the segment growth is the rise in the prevalence of cardiovascular conditions that call for pacemakers, such as atrial fibrillation, and the rising demand for minimally invasive procedures. Additionally, there is a rise in the number of cardiac pacemaker procedures is also boosting segment growth. According to the National Center for Biotechnology Information, around 1 million pacemaker procedures take placed every year globally. The adoption of cutting-edge technology and an increase in pacemaker research to create more compact devices are also promoting the segment growth.

Excerpts from ‘By Region Segmentation’

Based on region, the global heart blocks treatment market has been segmented into

North America
Europe
Asia Pacific
The Rest of The World

North America dominated the global heart blocks treatment market in 2021. The significant share of North America can be attributed to the rising incidence of CVDs and increased senescent population. Additionally, the increasing demand for minimally invasive procedures and the rise in pacemaker surgeries are fueling regional growth. According to the National Center for Biotechnology Information about 200,000 pacemakers are implanted in the U.S. every year. The region’s availability of a strong healthcare infrastructure, a favorable reimbursement policy, and increased CVD awareness contribute to the regional growth.

Excerpts from ‘Competitive Landscape’

The prominent players operating in the global heart blocks treatment market are

Boston Scientific Corporation
Medtronic Plc
Abbott Laboratories
BIOTRONIK SE & Co. KG
SORIN S.p.A
Edward Lifesciences Corporation
Novartis AG
Pfizer Inc.
Gilead Sciences Inc.
Janssen Pharmaceuticals Inc.
Sanofi S.A.
Merck & Co Inc.
Koninklijke Philips N.V.
Bayer AG
F. Hoffmann-La Roche AG
Natco Pharma and amongst others.

Inquire Before Buying This Research Report:

https://growthplusreports.com/inquiry/before-buying/heart-blocks-treatment-market/7969

Table of Content

INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
  1. Historical Years – 2020
  2. Base Year – 2021
  3. Forecasted Years – 2022 to 2030
3. Currency Used in the Report
RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
  1. Secondary Sources
  2. Primary Sources
4. Market Estimation Approach
  1. Bottom Up
  2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
MARKET DYNAMICS
1. Drivers
2. Restraints/Challenges
3. Opportunities
GLOBAL HEART BLOCKS TREATMENT MARKET – ANALYSIS & FORECAST, BY TYPE
1. First-degree heart blocks
2. Second-degree heart blocks
  1. Type I second degree AV block (Mobitz I)
  2. Type 2 second degree AV block (Mobitz II)
  3. Left bundle branch block
    1. Left anterior fascicular block
    2. Left posterior fascicular block
  4. Right bundle branch block
3. Third-degree heart blocks
  1. Congenital
  2. Acquired
GLOBAL HEART BLOCKS TREATMENT MARKET – ANALYSIS & FORECAST, BY TREATMENT
1. Pacemaker
2. Transcutaneous pacing (TCP)
3. Medication
  1. Anti-arrhythmic drugs
4. Follow-up electrophysiology study

TOC Continue…

VALUE PROPOSITIONS RELATED TO THE REPORT:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

CUSTOMIZATION OPTIONS:

Distributor Landscape Assessment
Pipeline Assessment
Pricing Intelligence
Customer Base Assessment
Investment & Initiatives Analysis
‘Business Profile’ of Key Players

Quickly Purchase Premium Copy of Heart Blocks Treatment Market Report:

https://growthplusreports.com/checkout?_token=G2Qb83YVVkLLcL7Mjvq8AiXw8ciW9V4DapBAsazQ&report_id=7969&license=Single

About Us

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.

CONTACT: Manan Sethi Director, Market Insights Email: [email protected] Phone no: +91 96545 76783 Web: https://growthplusreports.com/

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. NewIndiaObserver.com takes no editorial responsibility for the same.